The company said the less expensive drugs could decrease costs by 20-30 percent when using European market as a model. However, Steven Lucio, director of pharmacy clinical solutions for Novation, said implementation of biosimilars will be a complicated process. Novation plans to expand two of its resources, the Drug Monograph Service and the biannual Drug Price Forecast, to include the availability of biosimilars.
Related Articles on the Supply Chain:
Developing and Launching a Long-Sleeved Scrub: Q&A With Myrna Chang of CA’s O’Connor Hospital and Jennifer Walrich of Medline
Counterfeit Version of Cancer Drug Avastin Found in U.S.
GHX to Create Industry’s First Implantable Devices Supply Chain Solution for Physician Preference Items
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
